Results 111 to 120 of about 5,707,439 (181)

Green‐Synthesized Silver Nanoparticles Against Acinetobacter baumannii: A Systematic Review of Antibacterial Activity, Mechanisms of Action, Toxicity, and Antibiofilm Effects

MicrobiologyOpen, Volume 15, Issue 4, August 2026.
Schematic overview of the main antibacterial mechanisms proposed for green‐synthesized silver nanoparticles (AgNPs) against Acinetobacter baumannii. The figure summarizes the phytosynthetic pathway used to produce AgNPs (right panel) and the major reported antibacterial effects, including reactive oxygen species generation, oxidative stress, membrane ...
Shahla Shahbazi, Kimia Rafieibuzhani, Keyghobad Ghadiri, Yadollah Bahrami, Roya Chegene Lorestani, Maryam Meskini, Samira Sabzi, Mosayeb Rostamian   +7 more
wiley   +1 more source

AdeABC Efflux Pump Controlled by AdeRS Two Component System Conferring Resistance to Tigecycline, Omadacycline and Eravacycline in Clinical Carbapenem Resistant Acinetobacter nosocomialis

Frontiers in Microbiology, 2020
Carbapenem-resistant Acinetobacter nosocomialis (CRAn) is a significant public health concern. Tigecycline non-susceptible CRAn (Tn-CRAn) isolates have emerged worldwide.
Yi-Tzu Lee, Yi-Tzu Lee, Hsing-Yu Chen, Ya-Sung Yang, Yu-Ching Chou, Tein-Yao Chang, Wei-Jane Hsu, I-Chieh Lin, ACTION Study Group, Jun-Ren Sun   +9 more
doaj   +1 more source

Longitudinal Molecular Epidemiology and Genomic Surveillance of Carbapenem‐Resistant Klebsiella pneumoniae in the Gut of Healthy Individuals in China

MedComm, Volume 7, Issue 8, August 2026.
Using 16,040 stool samples from healthy individuals across 30 Chinese provinces (2016–2024), we performed longitudinal genomic surveillance of carbapenem‑resistant Klebsiella pneumoniae (CRKP) colonizing the gut. We reveal rising community CRKP prevalence, especially in southern China, a shift from blaKPC‐2 to plasmid‑borne blaNDM‐5 on IncHI2/IncHI2A ...
Zelin Yan, Yan Li, Yi Sun, Qiaoling Sun, Congcong Liu, Yanyan Zhang, Yuchen Wu, Hongwei Zhou, Shangshang Qin, Gongxiang Chen, Ruichao Li, Rong Zhang   +11 more
wiley   +1 more source

Five-Years Tigecycline Experience an Analysis of Real-Life Data [PDF]

, 2018
Aim: Tigecycline has been approved by the Food and Drug Administration for the treatment of complicated intra-abdominal infections, skin and soft tissue infections and community-acquired pneumonia.
Fatma Şebnem Erdinç, Günay Tuncer Ertem, Bulut, Cemal, Erdinç, Fatma Şebnem, Fatih Temocin, Cemal Bulut, Çiğdem Ataman Hatipoğlu, Sami Kınıklı, Necla Eren Tülek, Ertem, Günay Tuncer, Tuba Ilgar, Tülek, Necla Eren, Şirin Hekimoğlu, Temoçin, Fatih, Ilgar, Tuba, Hekimoğlu, Şirin   +15 more
core   +1 more source

Tigecycline Susceptibility in Multidrug Resistant Acinetobacter Isolates from Turkey

Polish Journal of Microbiology, 2013
The present study aimed to evaluate antimicrobial activity of tigecydcline against 84 multidrug resistant (MDR) Acinetobacter spp. strains by disc diffusion and E-test methods. The results of disc diffusion test were compared according to two different interpretation ways.
Yilmaz, Fethiye Ferda, Tasli, Huseyin, Gul-Yurtsever, Sureyya, Buyuk, Ayca, Hosgor-Limoncu, Mine   +4 more
openaire   +5 more sources

Transient AdeABC-mediated eravacycline resistance in carbapenem-resistant Acinetobacter baumannii ST2: a mutation-independent efflux pump adaptation

Annals of Clinical Microbiology and Antimicrobials
Purpose This study evaluated the impact of sub-MIC eravacycline exposure on carbapenem-resistant Acinetobacter baumannii with tigecycline MIC ≥ 8 µg/mL in clinical laboratory testing, and analyzed the resistance mechanisms. Methods 2144 A.
Xu Yang, Nanhao He, Anwarul Haque, Ying Mai, Jiong Wang, Shunian Xiao, Chao Zhuo   +6 more
doaj   +1 more source

Tigecycline Susceptibility of Carbapenem Resistant Enterobacteriaceae and Acinetobacter spp. isolates from Respiratory Tract: A Tertiary Care Centre Study [PDF]

Journal of Krishna Institute of Medical Sciences University, 2020
Background: Tigecycline is used as a last line of defence against Multidrug Resistant (MDR) strains, and increasing rates of resistance are a growing concern globally. Tigecycline resistance has been reported in various pathogens including Acinetobacter
Ashish Bajaj, Bibhabati Mishra, Poonam S. Loomba, Archana Thakur, Abha Sharma, Prachala G. Rathod, Madhusmita Das, Ashna Bhasin   +7 more
doaj  

β-lactamase-producing Gram negative isolates and molecular mechanisms involved in the expression of tigecycline resistance

, 2014
Objectives: The emergence of antibiotic resistant Gram negative bacteria, particularly β-lactamase-producing bacteria, seriously compromises the efficacy of the treatment options available.
Barbosa, Stephanie, Ferreira, Eugénia, Caniça, Manuela, Manageiro, Vera, Antimicrobial Resistance Surveillance Program in Portugal (ARSIP), Jones-Dias, Daniela   +5 more
core  

Mechanisms of tigecycline resistance in the Enterobacteriaceae and Acinetobacter baumannii [PDF]

, 2011
Tigecycline is the first glycylcycline to enter clinical use and displays good in vitro activity against a broad range of Gram-positive and Gram-negative pathogens.
Hornsey, Michael Andrew
core   +1 more source

Genomic insights into tigecycline non-susceptibility in Clostridioides difficile: the role of the Tet P determinant and efflux mechanisms

BMC Microbiology
Background Clostridioides difficile infection (CDI) is a significant cause of nosocomial infections, often arising from antibiotic-induced disruption of the normal gut microbiota, enabling C. difficile proliferation.
Zijun Dang, Peiwen Xia, Jinzhu Huang, Bingxue Yang, Jiajia Liao, Qi Han, Yun Xia   +6 more
doaj   +1 more source